Status:
UNKNOWN
Tailored Pharmacist-led Intervention to Improve Adherence to Budesonide
Lead Sponsor:
Shaoxing Maternity and Child Health Care Hospital
Conditions:
Asthma in Children
Eligibility:
All Genders
6-14 years
Phase:
NA
Brief Summary
Gaining control of asthma can be especially difficult during childhood as children undergo a variety of biological, developmental, and psychosocial changes. This study was designed to evaluate the imp...
Detailed Description
The patient in the intervention group received pharmacist-led multidisciplinary care. The multidisciplinary team consists of a physician, a pharmacist and a nurse. To ensure the uniformity of the mate...
Eligibility Criteria
Inclusion
- 6-14 years-of-age
- Met the diagnostic criteria described by the "Recommendations for Standardized Diagnosis and Treatment of Bronchial Asthma in Children (2020 Edition)"
- Dysfunctional lung function with a positive provocation test
- No previous respiratory rehabilitation treatment
- The parents' written informed consent.
Exclusion
- Acute exacerbation of asthma
- The co-existence of other respiratory system diseases (such as bronchopneumonia and bronchopulmonary dysplasia), cardiovascular system diseases (myocarditis and congenital heart disease), motor nervous system diseases
- The presence of mental disorders or the patient had psychological abnormalities and could not cooperate.
Key Trial Info
Start Date :
January 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT06080945
Start Date
January 4 2022
End Date
June 30 2024
Last Update
October 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaoxing Maternity and Child Care hospital
Shaoxing, Zhejiang, China, 312000